Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Japan first to approve Roche’s lung cancer drug alectinib

Personalised medicine has same target as Pfizer’s Xalkori and Novartis’ Zykadia

- PMLiVE

GSK wins approval for skin cancer drug Mekinist in EU

Will compete with Roche’s Zelboraf and BMS’ Yervoy in melanoma

- PMLiVE

Cello Health Insight appoints Marie Innes

She joins as a director from Kantar Health

- PMLiVE

Honour for mental health campaigner Marjorie Wallace

SANE founder receives healthcare advocate prize at Communiqué Awards 2014

- PMLiVE

DJM Digital Solutions is Specialist Consultancy of the Year

Agency takes honour at Communiqué Awards 2014

- PMLiVE

The moving parts of orphan drug development

Tackling rare diseases requires high levels of cooperation, regulatory support and a determination to succeed

- PMLiVE

FDA gives early green light to Spectrum’s lymphoma drug

Beleodaq approved to treat rare cancer

- PMLiVE

Lucid wins med ed consultancy of the year

Second victory in a row at Communiqué Awards

Boehringer Ingelheim headquarters

Boehringer submits COPD combo in EU

Combines Spiriva and Striverdi

- PMLiVE

MSD’s Kate Tillett rewarded for healthcare comms excellence

Company's external affairs director wins at Communiqué 2014

- PMLiVE

Roche wins In-House Team of the Year at Communiqué Awards

"Brave and courageous" UK communications team picks up honour

- PMLiVE

Pegasus wins Consultancy of the Year at Communiqué 2014

Brighton-based comms agency praised for focus, authenticity and delivery

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links